Table 1 Basal characteristics of intended-to-treat population (ITT) population (mean ± SD)
Placebo (n = 34) | Mobilee™ (n = 34) | p value | |
|---|---|---|---|
Gender (male/female) | 8/26 | 13/21 | 0.195 |
Age | 53.6 ± 8.94 | 56.1 ± 8.08 | 0.458 |
Muscular strength of the affected knee (Nm) (peak torque, extension at 240°/s) | 64.1 ± 24.83 | 65.4 ± 27.75 | 0.838 |
Degree of synovial effusion (mm) | 3.7 ± 2.15 | 4.2 ± 2.3 | 0.285 |
Pain intensity (cm) | 39.6 ± 4.86 | 42.3 ± 5.67 | 0.414 |
Quality-of-life SF-36 | |||
Physic component (PCS-36) | 42.6 ± 10.26 | 41.2 ± 9.34 | 0.798 |
Mental component (MCS-36) | 44.9 ± 12.79 | 50.1 ± 8.12 | 0.194 |